• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续性HPV52和HPV58阳性对宫颈病变管理的意义。

Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical Lesions.

作者信息

Yi Baozhu, Xu Qian, Zhang Zhixuan, Zhang Jinyi, Xu Yi, Huang Luoqi, Hu Yue, Tu Quanmei, Chen Jingyun

机构信息

Department of Gynecology, Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.

Department of Gynecology, Yiwu Maternity and Children Health Care Hospital, Jinhua, China.

出版信息

Front Oncol. 2022 May 18;12:812076. doi: 10.3389/fonc.2022.812076. eCollection 2022.

DOI:10.3389/fonc.2022.812076
PMID:35692793
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9175636/
Abstract

OBJECTIVE

This study aimed to compare the variability of HPV16/18/52/58 subtype infections in patients with different cervical lesions, to explore the guiding significance of persistent positive HPV subtypes 52 and 58 in the stratified management of cervical lesions, and to determine the appropriate management model.

METHOD

This study was conducted through a retrospective analysis of 244,218 patients who underwent HPV testing at the Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University from September 2014 to December 2020 to examine the distribution of different types of HPV infection. From March 2015 to September 2017, 3,014 patients with known HPV underwent colposcopy to analyze high-risk HPV infection for different cervical lesions. Meanwhile, from September 2014 to December 2020, 1,616 patients positive for HPV16/18/52/58 alone with normal TCT who underwent colposcopy in our hospital were retrospectively analyzed for the occurrence of cervical and vulvovaginal lesions, with colposcopic biopsy pathology results serving as the gold standard for statistical analysis.

RESULT

Analysis of 244,218 patients who had HPV tested revealed that the top 3 high-risk HPV types were HPV52, HPV58, and HPV16. Further analysis of 3,014 patients showed that 78.04% of patients referred for colposcopy had HPV16/18/52/58 alone. Among high-grade squamous intraepithelial lesions (HSIL) and cervical cancer, the most common is HPV16, followed by HPV58 and then HPV52 ( < 0.05). A total of 1,616 patients with normal TCT who were referred for colposcopy due to HPV16/18/52/58 infection were further analyzed. Based on pathological findings in lesions of HSIL and CC, HPV16 is the most common, followed by HPV58 and then HPV18 ( < 0.05). In the 1,616 patients analyzed, high-grade vulvovaginal lesions were detected, with HPV58 being the most common, followed by HPV16 and then HPV52 ( < 0.05).

CONCLUSION

  1. In patients with positive HPV58 alone and normal TCT, the indications for colposcopy may be relaxed, with particular attention paid to the possibility of vulvar and vaginal lesions.2. Patients with a positive HPV type 52 alone and normal TCT may be considered for a follow-up review and, if necessary, a colposcopy.3. The development of a more suitable HPV vaccine for the Asian population, such as HPV16/18/52/58, may better protect women's health.
摘要

目的

本研究旨在比较不同宫颈病变患者中HPV16/18/52/58亚型感染的变异性,探讨HPV52和58持续阳性在宫颈病变分层管理中的指导意义,并确定合适的管理模式。

方法

本研究通过回顾性分析2014年9月至2020年12月在温州医科大学附属第二医院育英儿童医院接受HPV检测的244218例患者,以研究不同类型HPV感染的分布情况。2015年3月至2017年9月,对3014例已知HPV的患者进行阴道镜检查,以分析不同宫颈病变的高危HPV感染情况。同时,回顾性分析2014年9月至2020年12月在我院因HPV16/18/52/58单独阳性且TCT正常而接受阴道镜检查的1616例患者宫颈和外阴阴道病变的发生情况,以阴道镜活检病理结果作为统计分析的金标准。

结果

对244218例进行HPV检测的患者分析显示,高危HPV前三位类型为HPV52、HPV58和HPV16。对3014例患者的进一步分析显示,接受阴道镜检查的患者中有78.04%仅感染HPV16/18/52/58。在高级别鳞状上皮内病变(HSIL)和宫颈癌中,最常见的是HPV16,其次是HPV58,然后是HPV52(P<0.05)。对因HPV16/18/52/58感染而接受阴道镜检查且TCT正常的1616例患者进行进一步分析。根据HSIL和CC病变的病理结果,HPV16最常见,其次是HPV58,然后是HPV18(P<0.05)。在分析的1616例患者中,检测到高级别外阴阴道病变,其中HPV58最常见,其次是HPV16,然后是HPV52(P<0.05)。

结论

  1. 对于仅HPV58阳性且TCT正常的患者,可放宽阴道镜检查指征,尤其要注意外阴和阴道病变的可能性。2. 对于仅HPV52阳性且TCT正常的患者,可考虑进行随访复查,必要时进行阴道镜检查。3. 开发更适合亚洲人群的HPV疫苗,如HPV16/18/52/58,可能会更好地保护女性健康。
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9696/9175636/3564814972b3/fonc-12-812076-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9696/9175636/3564814972b3/fonc-12-812076-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9696/9175636/3564814972b3/fonc-12-812076-g001.jpg

相似文献

1
Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical Lesions.持续性HPV52和HPV58阳性对宫颈病变管理的意义。
Front Oncol. 2022 May 18;12:812076. doi: 10.3389/fonc.2022.812076. eCollection 2022.
2
[Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].[不同HPV亚型感染合并细胞学异常状态下CIN2+/CIN3+风险的评估]
Zhonghua Zhong Liu Za Zhi. 2018 Mar 23;40(3):232-238. doi: 10.3760/cma.j.issn.0253-3766.2018.03.015.
3
Clinical and epidemiological features of high-risk human papillomavirus infection in patients with cervical intraepithelial lesions.宫颈上皮内病变患者高危型人乳头瘤病毒感染的临床和流行病学特征。
BMC Womens Health. 2023 Sep 1;23(1):468. doi: 10.1186/s12905-023-02583-x.
4
Risks for cervical abnormalities in women with non-16/18 high-risk human papillomavirus infections in south Shanghai, China.中国上海南部地区,非 16/18 型高危型人乳头瘤病毒感染女性的宫颈异常风险。
J Med Virol. 2021 Nov;93(11):6355-6361. doi: 10.1002/jmv.27185. Epub 2021 Jul 18.
5
[Prevalence of high-risk HPV and its distribution in cervical precancerous lesions among 35-64 years old women who received cervical cancer screening in Beijing].[北京市35-64岁接受宫颈癌筛查女性高危型人乳头瘤病毒的流行情况及其在宫颈上皮内瘤变中的分布]
Zhonghua Yu Fang Yi Xue Za Zhi. 2018 May 6;52(5):493-497. doi: 10.3760/cma.j.issn.0253-9624.2018.05.008.
6
Distribution of human papillomavirus genotypes in cervical lesions.宫颈病变中人类乳头瘤病毒基因型的分布
Exp Ther Med. 2017 Feb;13(2):535-541. doi: 10.3892/etm.2016.4000. Epub 2016 Dec 27.
7
Comprehensive overview of genotype distribution and prevalence of human papillomavirus in cervical lesions.宫颈病变中人类乳头瘤病毒基因型分布与流行情况的综合概述
Gynecol Obstet Clin Med. 2024 Apr;4(1). doi: 10.1136/gocm-2024-000005.
8
The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China.人乳头瘤病毒基因分型在细胞学正常的 HPV 阳性女性中检测高级别上皮内瘤变或癌症的作用:来自中国东北地区一家医院的研究。
BMC Cancer. 2020 May 19;20(1):443. doi: 10.1186/s12885-020-06935-w.
9
Epidemiological study of HPV infection in 40,693 women in Putian: a population study based on screening for high-risk HPV infection.莆田市 40693 例妇女 HPV 感染的流行病学研究:基于高危型 HPV 感染筛查的人群研究。
BMC Infect Dis. 2022 Nov 28;22(1):893. doi: 10.1186/s12879-022-07893-3.
10
Prevalence and genotype distribution of high-risk human papillomavirus infection among women with cervical cytological abnormalities in Chongqing, China, 2014-2020.2014-2020 年中国重庆宫颈细胞学异常女性中高危型人乳头瘤病毒感染的流行状况和基因型分布。
Diagn Cytopathol. 2021 Dec;49(12):1237-1243. doi: 10.1002/dc.24891. Epub 2021 Oct 28.

引用本文的文献

1
HPV16/HPV58 viral load is non-linearly correlated with cervical lesions and can be used as a triage marker.人乳头瘤病毒16型/人乳头瘤病毒58型病毒载量与宫颈病变呈非线性相关,可作为一种分流标志物。
Infect Agent Cancer. 2025 Jul 22;20(1):48. doi: 10.1186/s13027-025-00684-w.
2
Operational Feasibility and Performance of mRPA Versus PCR for the Detection of HPV Types 16, 18, and 52 in Clinical Samples: An Exploratory Study.用于检测临床样本中16、18和52型人乳头瘤病毒的mRPA与PCR的操作可行性及性能:一项探索性研究
Int J Womens Health. 2025 Apr 5;17:955-964. doi: 10.2147/IJWH.S496621. eCollection 2025.
3
PAX1/SOX1 DNA Methylation Versus Cytology and HPV16/18 Genotyping for the Triage of High-Risk HPV-Positive Women in Cervical Cancer Screening: Retrospective Analysis of Archival Samples.

本文引用的文献

1
Structural basis for the shared neutralization mechanism of three classes of human papillomavirus type 58 antibodies with disparate modes of binding.三类结合模式不同的人乳头瘤病毒58型抗体共享中和机制的结构基础
J Virol. 2021 Mar 10;95(7). doi: 10.1128/JVI.01587-20. Epub 2021 Jan 20.
2
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
3
Exploring the dynamics and interplay of human papillomavirus and cervical tumorigenesis by integrating biological data into a mathematical model.
PAX1/SOX1 DNA甲基化与细胞学及HPV16/18基因分型在宫颈癌筛查中对高危HPV阳性女性进行分流的比较:存档样本的回顾性分析
BJOG. 2025 Jan;132(2):197-204. doi: 10.1111/1471-0528.17965. Epub 2024 Sep 26.
4
High-Risk Genotypes of Human Papillomavirus at Diverse Anogenital Sites among Chinese Women: Infection Features and Potential Correlation with Cervical Intraepithelial Neoplasia.中国女性不同肛门生殖器部位人乳头瘤病毒的高危基因型:感染特征及与宫颈上皮内瘤变的潜在相关性
Cancers (Basel). 2024 May 31;16(11):2107. doi: 10.3390/cancers16112107.
5
Characteristic of persistent human papillomavirus infection in women worldwide: a meta-analysis.全球女性持续性人乳头瘤病毒感染的特征:一项荟萃分析。
PeerJ. 2023 Nov 14;11:e16247. doi: 10.7717/peerj.16247. eCollection 2023.
6
The Effect of Cervical Cold-Knife Conization (CKC) on HPV Infection in Patients with High-Grade Cervical Intraepithelial Neoplasia: A Retrospective Study.宫颈冷刀锥切术(CKC)对高级别宫颈上皮内瘤变患者HPV感染的影响:一项回顾性研究
Int J Womens Health. 2023 Nov 2;15:1681-1691. doi: 10.2147/IJWH.S429749. eCollection 2023.
7
Epidemiologic characteristics of high-risk HPV and the correlation between multiple infections and cervical lesions.高危型 HPV 的流行病学特征及多重感染与宫颈病变的相关性。
BMC Infect Dis. 2023 Oct 7;23(1):667. doi: 10.1186/s12879-023-08634-w.
通过将生物学数据整合到数学模型中,探索人乳头瘤病毒和宫颈癌发生的动态和相互作用。
BMC Bioinformatics. 2020 May 5;21(Suppl 7):152. doi: 10.1186/s12859-020-3454-5.
4
An efficient method that combines the ThinPrep cytologic test with E6/E7 mRNA testing for cervical cancer screening.一种将液基薄层细胞学检测与E6/E7 mRNA检测相结合用于宫颈癌筛查的有效方法。
Cancer Manag Res. 2019 May 24;11:4773-4780. doi: 10.2147/CMAR.S197749. eCollection 2019.
5
Screening for HPV infection in exfoliated cervical cells of women from different ethnic groups in Yili, Xinjiang, China.中国新疆伊犁地区不同民族妇女宫颈细胞脱落物中人乳头瘤病毒感染的筛查。
Sci Rep. 2019 Mar 5;9(1):3468. doi: 10.1038/s41598-019-39790-2.
6
Making HPV vaccination available to girls everywhere.为世界各地的女孩提供 HPV 疫苗接种。
Int J Gynaecol Obstet. 2018 Dec;143(3):267-276. doi: 10.1002/ijgo.12656. Epub 2018 Sep 12.
7
Risk Prediction of Cervical Cancer and Precancers by Type-Specific Human Papillomavirus: Evidence from a Population-Based Cohort Study in China.基于人群的队列研究在中国对 HPV 型别特异的宫颈癌及癌前病变的风险预测。
Cancer Prev Res (Phila). 2017 Dec;10(12):745-751. doi: 10.1158/1940-6207.CAPR-17-0088. Epub 2017 Sep 15.
8
Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva.外阴鳞状细胞癌和上皮内瘤变中人乳头瘤病毒的患病率及类型分布
Int J Cancer. 2017 Sep 15;141(6):1161-1169. doi: 10.1002/ijc.30821. Epub 2017 Jun 21.
9
Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence.用于癌症预防的人乳头瘤病毒9价疫苗:现有证据的系统评价
Epidemiol Infect. 2017 Jul;145(10):1962-1982. doi: 10.1017/S0950268817000747. Epub 2017 Apr 27.
10
Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis.全球各地区和收入水平的人乳头瘤病毒疫苗接种覆盖率估计:汇总分析。
Lancet Glob Health. 2016 Jul;4(7):e453-63. doi: 10.1016/S2214-109X(16)30099-7.